Global Neurovascular Devices Supply, Demand and Key Producers, 2026-2032
The global Neurovascular Devices market size is expected to reach $ 4692 million by 2032, rising at a market growth of 5.2% CAGR during the forecast period (2026-2032).
Neurovascular devices are medical devices used to diagnose, treat, and manage various diseases affecting the blood vessels in the brain and nervous system. Neurovascular diseases typically include conditions such as stroke (both ischemic and hemorrhagic), brain aneurysms, arteriovenous malformations (AVMs), and other vascular abnormalities. These devices play a critical role in neurovascular procedures, enabling minimally invasive treatments that enhance patient outcomes.
Common neurovascular devices include stents, coils, embolization devices, flow diversion devices, microcatheters, aspiration systems, and intracranial pressure (ICP) monitors. Stents are primarily used to treat narrowed blood vessels, often in patients with cerebral aneurysms or carotid artery disease. Coils are used to embolize brain aneurysms, promoting clot formation inside the aneurysm and reducing the risk of rupture. Flow diversion devices are used to alter blood flow in the brain, typically for aneurysm treatment, to reduce the risk of rupture. Microcatheters and embolization devices are mainly used to occlude abnormal blood vessels in conditions like AVMs or tumors. Aspiration devices are employed to remove blood clots in acute ischemic strokes, restoring blood flow to the brain.
These devices have significantly advanced the treatment of neurovascular diseases, improving the precision and safety of procedures. As medical technology progresses, the role of these devices in minimally invasive surgeries continues to grow, and they will remain essential in the development of the field of neurointervention and neurosurgery.
1. Market Development Opportunities and Key Drivers:
The market for neurovascular devices is driven by several key factors:
Rising Stroke Incidence: As the global population ages, the incidence of strokes, especially ischemic strokes, continues to increase, driving demand for neurovascular devices.
Technological Advancements: With the development of minimally invasive technologies, neurovascular procedures have become more precise and safer. New devices and materials, such as flow diversion devices and automated aspiration systems, have made neurointerventional procedures more efficient and feasible.
Expanded Healthcare Coverage: The expansion of healthcare insurance systems and increasing healthcare expenditures have driven the demand for effective medical devices.
Increased Health Awareness: As public awareness of cerebrovascular diseases rises, there is a growing demand for early diagnosis and prevention, further fueling the neurovascular device market.
2. Market Risks:
High Treatment Costs: Neurovascular devices are often expensive, particularly high-end devices and treatments, which may create entry barriers in developing countries.
Technological Risks: The development of new technologies is uncertain, requiring long clinical trials and regulatory approvals. Additionally, the rapid pace of technological advancements may render products obsolete.
Regulatory and Compliance Risks: The approval process for medical devices is stringent, especially for new technologies, and regulatory challenges may hinder market adoption.
3. Market Concentration:
The neurovascular device market is relatively concentrated, with a few leading global medical device companies dominating the market. Major players include Medtronic, Stryker, Boston Scientific, and others. These companies have strong R&D capabilities and extensive distribution networks, enabling them to provide high-quality products and maintain a dominant position globally.
4. Downstream Demand Trends:
Increasing Demand Due to Aging Population: As the global population ages, the prevalence of cerebrovascular diseases such as strokes continues to rise, driving the demand for neurovascular treatments and devices.
Preference for Minimally Invasive Procedures: Patients increasingly prefer minimally invasive surgeries, which reduce hospital stays and recovery times, leading to a growing demand for minimally invasive neurovascular devices.
Customized Treatment Needs: With the advancement of precision medicine, there is an increasing demand for personalized treatment solutions, which has led to the development of tailored neurovascular devices.
5. Latest Technologies:
Flow Diversion Devices: This technology has made significant progress in treating brain aneurysms, especially in high-risk patients, by diverting blood flow away from the aneurysm to reduce the risk of rupture.
Automated Aspiration Systems: These systems are used for clot retrieval in acute ischemic stroke, enabling rapid and effective restoration of blood flow to the brain.
Minimally Invasive Surgical Systems: Recent advancements in minimally invasive surgery have made neurovascular procedures more precise, reducing surgical risks and recovery times by using smaller catheters and more accurate techniques.
This report studies the global Neurovascular Devices demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neurovascular Devices, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neurovascular Devices that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neurovascular Devices total market, 2021-2032, (USD Million)
Global Neurovascular Devices total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Neurovascular Devices total market, key domestic companies, and share, (USD Million)
Global Neurovascular Devices revenue by player, revenue and market share 2021-2026, (USD Million)
Global Neurovascular Devices total market by Type, CAGR, 2021-2032, (USD Million)
Global Neurovascular Devices total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Neurovascular Devices market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Stryker Corporation, Johnson & Johnson, Medtronic, Terumo Neuro, Penumbra, Inc. (Neuro), Shanghai MicroPort Medical (Group) Co.?Ltd., Abbott Vascular, Medical Murray, Boston Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Neurovascular Devices market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Neurovascular Devices Market, By Region:
1. How big is the global Neurovascular Devices market?
2. What is the demand of the global Neurovascular Devices market?
3. What is the year over year growth of the global Neurovascular Devices market?
4. What is the total value of the global Neurovascular Devices market?
5. Who are the Major Players in the global Neurovascular Devices market?
6. What are the growth factors driving the market demand?
Neurovascular devices are medical devices used to diagnose, treat, and manage various diseases affecting the blood vessels in the brain and nervous system. Neurovascular diseases typically include conditions such as stroke (both ischemic and hemorrhagic), brain aneurysms, arteriovenous malformations (AVMs), and other vascular abnormalities. These devices play a critical role in neurovascular procedures, enabling minimally invasive treatments that enhance patient outcomes.
Common neurovascular devices include stents, coils, embolization devices, flow diversion devices, microcatheters, aspiration systems, and intracranial pressure (ICP) monitors. Stents are primarily used to treat narrowed blood vessels, often in patients with cerebral aneurysms or carotid artery disease. Coils are used to embolize brain aneurysms, promoting clot formation inside the aneurysm and reducing the risk of rupture. Flow diversion devices are used to alter blood flow in the brain, typically for aneurysm treatment, to reduce the risk of rupture. Microcatheters and embolization devices are mainly used to occlude abnormal blood vessels in conditions like AVMs or tumors. Aspiration devices are employed to remove blood clots in acute ischemic strokes, restoring blood flow to the brain.
These devices have significantly advanced the treatment of neurovascular diseases, improving the precision and safety of procedures. As medical technology progresses, the role of these devices in minimally invasive surgeries continues to grow, and they will remain essential in the development of the field of neurointervention and neurosurgery.
1. Market Development Opportunities and Key Drivers:
The market for neurovascular devices is driven by several key factors:
Rising Stroke Incidence: As the global population ages, the incidence of strokes, especially ischemic strokes, continues to increase, driving demand for neurovascular devices.
Technological Advancements: With the development of minimally invasive technologies, neurovascular procedures have become more precise and safer. New devices and materials, such as flow diversion devices and automated aspiration systems, have made neurointerventional procedures more efficient and feasible.
Expanded Healthcare Coverage: The expansion of healthcare insurance systems and increasing healthcare expenditures have driven the demand for effective medical devices.
Increased Health Awareness: As public awareness of cerebrovascular diseases rises, there is a growing demand for early diagnosis and prevention, further fueling the neurovascular device market.
2. Market Risks:
High Treatment Costs: Neurovascular devices are often expensive, particularly high-end devices and treatments, which may create entry barriers in developing countries.
Technological Risks: The development of new technologies is uncertain, requiring long clinical trials and regulatory approvals. Additionally, the rapid pace of technological advancements may render products obsolete.
Regulatory and Compliance Risks: The approval process for medical devices is stringent, especially for new technologies, and regulatory challenges may hinder market adoption.
3. Market Concentration:
The neurovascular device market is relatively concentrated, with a few leading global medical device companies dominating the market. Major players include Medtronic, Stryker, Boston Scientific, and others. These companies have strong R&D capabilities and extensive distribution networks, enabling them to provide high-quality products and maintain a dominant position globally.
4. Downstream Demand Trends:
Increasing Demand Due to Aging Population: As the global population ages, the prevalence of cerebrovascular diseases such as strokes continues to rise, driving the demand for neurovascular treatments and devices.
Preference for Minimally Invasive Procedures: Patients increasingly prefer minimally invasive surgeries, which reduce hospital stays and recovery times, leading to a growing demand for minimally invasive neurovascular devices.
Customized Treatment Needs: With the advancement of precision medicine, there is an increasing demand for personalized treatment solutions, which has led to the development of tailored neurovascular devices.
5. Latest Technologies:
Flow Diversion Devices: This technology has made significant progress in treating brain aneurysms, especially in high-risk patients, by diverting blood flow away from the aneurysm to reduce the risk of rupture.
Automated Aspiration Systems: These systems are used for clot retrieval in acute ischemic stroke, enabling rapid and effective restoration of blood flow to the brain.
Minimally Invasive Surgical Systems: Recent advancements in minimally invasive surgery have made neurovascular procedures more precise, reducing surgical risks and recovery times by using smaller catheters and more accurate techniques.
This report studies the global Neurovascular Devices demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Neurovascular Devices, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neurovascular Devices that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Neurovascular Devices total market, 2021-2032, (USD Million)
Global Neurovascular Devices total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Neurovascular Devices total market, key domestic companies, and share, (USD Million)
Global Neurovascular Devices revenue by player, revenue and market share 2021-2026, (USD Million)
Global Neurovascular Devices total market by Type, CAGR, 2021-2032, (USD Million)
Global Neurovascular Devices total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Neurovascular Devices market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Stryker Corporation, Johnson & Johnson, Medtronic, Terumo Neuro, Penumbra, Inc. (Neuro), Shanghai MicroPort Medical (Group) Co.?Ltd., Abbott Vascular, Medical Murray, Boston Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Neurovascular Devices market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Neurovascular Devices Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Thrombectomy Devices
- Intracranial Stents
- Embolization Devices
- Flow Diversion Devices
- Others
- Stroke Treatment
- Aneurysm Treatment
- Cerebral Vascular Stenosis Treatment
- Traumatic Brain Injury and Intracranial Hemorrhage Treatment
- Others
- Stryker Corporation
- Johnson & Johnson
- Medtronic
- Terumo Neuro
- Penumbra, Inc. (Neuro)
- Shanghai MicroPort Medical (Group) Co.?Ltd.
- Abbott Vascular
- Medical Murray
- Boston Scientific
1. How big is the global Neurovascular Devices market?
2. What is the demand of the global Neurovascular Devices market?
3. What is the year over year growth of the global Neurovascular Devices market?
4. What is the total value of the global Neurovascular Devices market?
5. Who are the Major Players in the global Neurovascular Devices market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Neurovascular Devices Introduction
1.2 World Neurovascular Devices Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Neurovascular Devices Total Market by Region (by Headquarter Location)
1.3.1 World Neurovascular Devices Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Neurovascular Devices Revenue (2021-2032)
1.3.3 China Based Company Neurovascular Devices Revenue (2021-2032)
1.3.4 Europe Based Company Neurovascular Devices Revenue (2021-2032)
1.3.5 Japan Based Company Neurovascular Devices Revenue (2021-2032)
1.3.6 South Korea Based Company Neurovascular Devices Revenue (2021-2032)
1.3.7 ASEAN Based Company Neurovascular Devices Revenue (2021-2032)
1.3.8 India Based Company Neurovascular Devices Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neurovascular Devices Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Neurovascular Devices Consumption Value (2021-2032)
2.2 World Neurovascular Devices Consumption Value by Region
2.2.1 World Neurovascular Devices Consumption Value by Region (2021-2026)
2.2.2 World Neurovascular Devices Consumption Value Forecast by Region (2027-2032)
2.3 United States Neurovascular Devices Consumption Value (2021-2032)
2.4 China Neurovascular Devices Consumption Value (2021-2032)
2.5 Europe Neurovascular Devices Consumption Value (2021-2032)
2.6 Japan Neurovascular Devices Consumption Value (2021-2032)
2.7 South Korea Neurovascular Devices Consumption Value (2021-2032)
2.8 ASEAN Neurovascular Devices Consumption Value (2021-2032)
2.9 India Neurovascular Devices Consumption Value (2021-2032)
3 WORLD NEUROVASCULAR DEVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Neurovascular Devices Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Neurovascular Devices Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Neurovascular Devices in 2025
3.2.3 Global Concentration Ratios (CR8) for Neurovascular Devices in 2025
3.3 Neurovascular Devices Company Evaluation Quadrant
3.4 Neurovascular Devices Market: Overall Company Footprint Analysis
3.4.1 Neurovascular Devices Market: Region Footprint
3.4.2 Neurovascular Devices Market: Company Product Type Footprint
3.4.3 Neurovascular Devices Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Neurovascular Devices Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Neurovascular Devices Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Neurovascular Devices Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Neurovascular Devices Consumption Value Comparison
4.2.1 United States VS China: Neurovascular Devices Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Neurovascular Devices Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Neurovascular Devices Companies and Market Share, 2021-2026
4.3.1 United States Based Neurovascular Devices Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Neurovascular Devices Revenue, (2021-2026)
4.4 China Based Companies Neurovascular Devices Revenue and Market Share, 2021-2026
4.4.1 China Based Neurovascular Devices Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Neurovascular Devices Revenue, (2021-2026)
4.5 Rest of World Based Neurovascular Devices Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Neurovascular Devices Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Neurovascular Devices Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Neurovascular Devices Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Thrombectomy Devices
5.2.2 Intracranial Stents
5.2.3 Embolization Devices
5.2.4 Flow Diversion Devices
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Neurovascular Devices Market Size by Type (2021-2026)
5.3.2 World Neurovascular Devices Market Size by Type (2027-2032)
5.3.3 World Neurovascular Devices Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Neurovascular Devices Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Stroke Treatment
6.2.2 Aneurysm Treatment
6.2.3 Cerebral Vascular Stenosis Treatment
6.2.4 Traumatic Brain Injury and Intracranial Hemorrhage Treatment
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Neurovascular Devices Market Size by Application (2021-2026)
6.3.2 World Neurovascular Devices Market Size by Application (2027-2032)
6.3.3 World Neurovascular Devices Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Stryker Corporation
7.1.1 Stryker Corporation Details
7.1.2 Stryker Corporation Major Business
7.1.3 Stryker Corporation Neurovascular Devices Product and Services
7.1.4 Stryker Corporation Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Stryker Corporation Recent Developments/Updates
7.1.6 Stryker Corporation Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Details
7.2.2 Johnson & Johnson Major Business
7.2.3 Johnson & Johnson Neurovascular Devices Product and Services
7.2.4 Johnson & Johnson Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Johnson & Johnson Recent Developments/Updates
7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 Medtronic
7.3.1 Medtronic Details
7.3.2 Medtronic Major Business
7.3.3 Medtronic Neurovascular Devices Product and Services
7.3.4 Medtronic Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Medtronic Recent Developments/Updates
7.3.6 Medtronic Competitive Strengths & Weaknesses
7.4 Terumo Neuro
7.4.1 Terumo Neuro Details
7.4.2 Terumo Neuro Major Business
7.4.3 Terumo Neuro Neurovascular Devices Product and Services
7.4.4 Terumo Neuro Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Terumo Neuro Recent Developments/Updates
7.4.6 Terumo Neuro Competitive Strengths & Weaknesses
7.5 Penumbra, Inc. (Neuro)
7.5.1 Penumbra, Inc. (Neuro) Details
7.5.2 Penumbra, Inc. (Neuro) Major Business
7.5.3 Penumbra, Inc. (Neuro) Neurovascular Devices Product and Services
7.5.4 Penumbra, Inc. (Neuro) Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Penumbra, Inc. (Neuro) Recent Developments/Updates
7.5.6 Penumbra, Inc. (Neuro) Competitive Strengths & Weaknesses
7.6 Shanghai MicroPort Medical (Group) Co.?Ltd.
7.6.1 Shanghai MicroPort Medical (Group) Co.?Ltd. Details
7.6.2 Shanghai MicroPort Medical (Group) Co.?Ltd. Major Business
7.6.3 Shanghai MicroPort Medical (Group) Co.?Ltd. Neurovascular Devices Product and Services
7.6.4 Shanghai MicroPort Medical (Group) Co.?Ltd. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Shanghai MicroPort Medical (Group) Co.?Ltd. Recent Developments/Updates
7.6.6 Shanghai MicroPort Medical (Group) Co.?Ltd. Competitive Strengths & Weaknesses
7.7 Abbott Vascular
7.7.1 Abbott Vascular Details
7.7.2 Abbott Vascular Major Business
7.7.3 Abbott Vascular Neurovascular Devices Product and Services
7.7.4 Abbott Vascular Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Abbott Vascular Recent Developments/Updates
7.7.6 Abbott Vascular Competitive Strengths & Weaknesses
7.8 Medical Murray
7.8.1 Medical Murray Details
7.8.2 Medical Murray Major Business
7.8.3 Medical Murray Neurovascular Devices Product and Services
7.8.4 Medical Murray Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Medical Murray Recent Developments/Updates
7.8.6 Medical Murray Competitive Strengths & Weaknesses
7.9 Boston Scientific
7.9.1 Boston Scientific Details
7.9.2 Boston Scientific Major Business
7.9.3 Boston Scientific Neurovascular Devices Product and Services
7.9.4 Boston Scientific Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Boston Scientific Recent Developments/Updates
7.9.6 Boston Scientific Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Neurovascular Devices Industry Chain
8.2 Neurovascular Devices Upstream Analysis
8.3 Neurovascular Devices Midstream Analysis
8.4 Neurovascular Devices Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Neurovascular Devices Introduction
1.2 World Neurovascular Devices Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Neurovascular Devices Total Market by Region (by Headquarter Location)
1.3.1 World Neurovascular Devices Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Neurovascular Devices Revenue (2021-2032)
1.3.3 China Based Company Neurovascular Devices Revenue (2021-2032)
1.3.4 Europe Based Company Neurovascular Devices Revenue (2021-2032)
1.3.5 Japan Based Company Neurovascular Devices Revenue (2021-2032)
1.3.6 South Korea Based Company Neurovascular Devices Revenue (2021-2032)
1.3.7 ASEAN Based Company Neurovascular Devices Revenue (2021-2032)
1.3.8 India Based Company Neurovascular Devices Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Neurovascular Devices Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Neurovascular Devices Consumption Value (2021-2032)
2.2 World Neurovascular Devices Consumption Value by Region
2.2.1 World Neurovascular Devices Consumption Value by Region (2021-2026)
2.2.2 World Neurovascular Devices Consumption Value Forecast by Region (2027-2032)
2.3 United States Neurovascular Devices Consumption Value (2021-2032)
2.4 China Neurovascular Devices Consumption Value (2021-2032)
2.5 Europe Neurovascular Devices Consumption Value (2021-2032)
2.6 Japan Neurovascular Devices Consumption Value (2021-2032)
2.7 South Korea Neurovascular Devices Consumption Value (2021-2032)
2.8 ASEAN Neurovascular Devices Consumption Value (2021-2032)
2.9 India Neurovascular Devices Consumption Value (2021-2032)
3 WORLD NEUROVASCULAR DEVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Neurovascular Devices Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Neurovascular Devices Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Neurovascular Devices in 2025
3.2.3 Global Concentration Ratios (CR8) for Neurovascular Devices in 2025
3.3 Neurovascular Devices Company Evaluation Quadrant
3.4 Neurovascular Devices Market: Overall Company Footprint Analysis
3.4.1 Neurovascular Devices Market: Region Footprint
3.4.2 Neurovascular Devices Market: Company Product Type Footprint
3.4.3 Neurovascular Devices Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Neurovascular Devices Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Neurovascular Devices Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Neurovascular Devices Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Neurovascular Devices Consumption Value Comparison
4.2.1 United States VS China: Neurovascular Devices Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Neurovascular Devices Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Neurovascular Devices Companies and Market Share, 2021-2026
4.3.1 United States Based Neurovascular Devices Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Neurovascular Devices Revenue, (2021-2026)
4.4 China Based Companies Neurovascular Devices Revenue and Market Share, 2021-2026
4.4.1 China Based Neurovascular Devices Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Neurovascular Devices Revenue, (2021-2026)
4.5 Rest of World Based Neurovascular Devices Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Neurovascular Devices Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Neurovascular Devices Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Neurovascular Devices Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Thrombectomy Devices
5.2.2 Intracranial Stents
5.2.3 Embolization Devices
5.2.4 Flow Diversion Devices
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Neurovascular Devices Market Size by Type (2021-2026)
5.3.2 World Neurovascular Devices Market Size by Type (2027-2032)
5.3.3 World Neurovascular Devices Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Neurovascular Devices Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Stroke Treatment
6.2.2 Aneurysm Treatment
6.2.3 Cerebral Vascular Stenosis Treatment
6.2.4 Traumatic Brain Injury and Intracranial Hemorrhage Treatment
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Neurovascular Devices Market Size by Application (2021-2026)
6.3.2 World Neurovascular Devices Market Size by Application (2027-2032)
6.3.3 World Neurovascular Devices Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Stryker Corporation
7.1.1 Stryker Corporation Details
7.1.2 Stryker Corporation Major Business
7.1.3 Stryker Corporation Neurovascular Devices Product and Services
7.1.4 Stryker Corporation Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Stryker Corporation Recent Developments/Updates
7.1.6 Stryker Corporation Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Details
7.2.2 Johnson & Johnson Major Business
7.2.3 Johnson & Johnson Neurovascular Devices Product and Services
7.2.4 Johnson & Johnson Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Johnson & Johnson Recent Developments/Updates
7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 Medtronic
7.3.1 Medtronic Details
7.3.2 Medtronic Major Business
7.3.3 Medtronic Neurovascular Devices Product and Services
7.3.4 Medtronic Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Medtronic Recent Developments/Updates
7.3.6 Medtronic Competitive Strengths & Weaknesses
7.4 Terumo Neuro
7.4.1 Terumo Neuro Details
7.4.2 Terumo Neuro Major Business
7.4.3 Terumo Neuro Neurovascular Devices Product and Services
7.4.4 Terumo Neuro Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Terumo Neuro Recent Developments/Updates
7.4.6 Terumo Neuro Competitive Strengths & Weaknesses
7.5 Penumbra, Inc. (Neuro)
7.5.1 Penumbra, Inc. (Neuro) Details
7.5.2 Penumbra, Inc. (Neuro) Major Business
7.5.3 Penumbra, Inc. (Neuro) Neurovascular Devices Product and Services
7.5.4 Penumbra, Inc. (Neuro) Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Penumbra, Inc. (Neuro) Recent Developments/Updates
7.5.6 Penumbra, Inc. (Neuro) Competitive Strengths & Weaknesses
7.6 Shanghai MicroPort Medical (Group) Co.?Ltd.
7.6.1 Shanghai MicroPort Medical (Group) Co.?Ltd. Details
7.6.2 Shanghai MicroPort Medical (Group) Co.?Ltd. Major Business
7.6.3 Shanghai MicroPort Medical (Group) Co.?Ltd. Neurovascular Devices Product and Services
7.6.4 Shanghai MicroPort Medical (Group) Co.?Ltd. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Shanghai MicroPort Medical (Group) Co.?Ltd. Recent Developments/Updates
7.6.6 Shanghai MicroPort Medical (Group) Co.?Ltd. Competitive Strengths & Weaknesses
7.7 Abbott Vascular
7.7.1 Abbott Vascular Details
7.7.2 Abbott Vascular Major Business
7.7.3 Abbott Vascular Neurovascular Devices Product and Services
7.7.4 Abbott Vascular Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Abbott Vascular Recent Developments/Updates
7.7.6 Abbott Vascular Competitive Strengths & Weaknesses
7.8 Medical Murray
7.8.1 Medical Murray Details
7.8.2 Medical Murray Major Business
7.8.3 Medical Murray Neurovascular Devices Product and Services
7.8.4 Medical Murray Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Medical Murray Recent Developments/Updates
7.8.6 Medical Murray Competitive Strengths & Weaknesses
7.9 Boston Scientific
7.9.1 Boston Scientific Details
7.9.2 Boston Scientific Major Business
7.9.3 Boston Scientific Neurovascular Devices Product and Services
7.9.4 Boston Scientific Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Boston Scientific Recent Developments/Updates
7.9.6 Boston Scientific Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Neurovascular Devices Industry Chain
8.2 Neurovascular Devices Upstream Analysis
8.3 Neurovascular Devices Midstream Analysis
8.4 Neurovascular Devices Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Neurovascular Devices Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Neurovascular Devices Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Neurovascular Devices Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Neurovascular Devices Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Neurovascular Devices Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Neurovascular Devices Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Neurovascular Devices Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Neurovascular Devices Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Neurovascular Devices Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Neurovascular Devices Players in 2025
Table 12. World Neurovascular Devices Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Neurovascular Devices Company Evaluation Quadrant
Table 14. Head Office of Key Neurovascular Devices Players
Table 15. Neurovascular Devices Market: Company Product Type Footprint
Table 16. Neurovascular Devices Market: Company Product Application Footprint
Table 17. Neurovascular Devices Mergers & Acquisitions Activity
Table 18. United States VS China Neurovascular Devices Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Neurovascular Devices Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Neurovascular Devices Companies, Headquarters (States, Country)
Table 21. United States Based Companies Neurovascular Devices Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Neurovascular Devices Revenue Market Share (2021-2026)
Table 23. China Based Neurovascular Devices Companies, Headquarters (Province, Country)
Table 24. China Based Companies Neurovascular Devices Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Neurovascular Devices Revenue Market Share (2021-2026)
Table 26. Rest of World Based Neurovascular Devices Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Neurovascular Devices Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Neurovascular Devices Revenue Market Share (2021-2026)
Table 29. World Neurovascular Devices Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Neurovascular Devices Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Neurovascular Devices Market Size by Type (2027-2032) & (USD Million)
Table 32. World Neurovascular Devices Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Neurovascular Devices Market Size by Application (2021-2026) & (USD Million)
Table 34. World Neurovascular Devices Market Size by Application (2027-2032) & (USD Million)
Table 35. Stryker Corporation Basic Information, Manufacturing Base and Competitors
Table 36. Stryker Corporation Major Business
Table 37. Stryker Corporation Neurovascular Devices Product and Services
Table 38. Stryker Corporation Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Stryker Corporation Recent Developments/Updates
Table 40. Stryker Corporation Competitive Strengths & Weaknesses
Table 41. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 42. Johnson & Johnson Major Business
Table 43. Johnson & Johnson Neurovascular Devices Product and Services
Table 44. Johnson & Johnson Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Johnson & Johnson Recent Developments/Updates
Table 46. Johnson & Johnson Competitive Strengths & Weaknesses
Table 47. Medtronic Basic Information, Manufacturing Base and Competitors
Table 48. Medtronic Major Business
Table 49. Medtronic Neurovascular Devices Product and Services
Table 50. Medtronic Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Medtronic Recent Developments/Updates
Table 52. Medtronic Competitive Strengths & Weaknesses
Table 53. Terumo Neuro Basic Information, Manufacturing Base and Competitors
Table 54. Terumo Neuro Major Business
Table 55. Terumo Neuro Neurovascular Devices Product and Services
Table 56. Terumo Neuro Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Terumo Neuro Recent Developments/Updates
Table 58. Terumo Neuro Competitive Strengths & Weaknesses
Table 59. Penumbra, Inc. (Neuro) Basic Information, Manufacturing Base and Competitors
Table 60. Penumbra, Inc. (Neuro) Major Business
Table 61. Penumbra, Inc. (Neuro) Neurovascular Devices Product and Services
Table 62. Penumbra, Inc. (Neuro) Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Penumbra, Inc. (Neuro) Recent Developments/Updates
Table 64. Penumbra, Inc. (Neuro) Competitive Strengths & Weaknesses
Table 65. Shanghai MicroPort Medical (Group) Co.?Ltd. Basic Information, Manufacturing Base and Competitors
Table 66. Shanghai MicroPort Medical (Group) Co.?Ltd. Major Business
Table 67. Shanghai MicroPort Medical (Group) Co.?Ltd. Neurovascular Devices Product and Services
Table 68. Shanghai MicroPort Medical (Group) Co.?Ltd. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Shanghai MicroPort Medical (Group) Co.?Ltd. Recent Developments/Updates
Table 70. Shanghai MicroPort Medical (Group) Co.?Ltd. Competitive Strengths & Weaknesses
Table 71. Abbott Vascular Basic Information, Manufacturing Base and Competitors
Table 72. Abbott Vascular Major Business
Table 73. Abbott Vascular Neurovascular Devices Product and Services
Table 74. Abbott Vascular Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Abbott Vascular Recent Developments/Updates
Table 76. Abbott Vascular Competitive Strengths & Weaknesses
Table 77. Medical Murray Basic Information, Manufacturing Base and Competitors
Table 78. Medical Murray Major Business
Table 79. Medical Murray Neurovascular Devices Product and Services
Table 80. Medical Murray Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Medical Murray Recent Developments/Updates
Table 82. Medical Murray Competitive Strengths & Weaknesses
Table 83. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 84. Boston Scientific Major Business
Table 85. Boston Scientific Neurovascular Devices Product and Services
Table 86. Boston Scientific Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Boston Scientific Recent Developments/Updates
Table 88. Boston Scientific Competitive Strengths & Weaknesses
Table 89. Global Key Players of Neurovascular Devices Upstream (Raw Materials)
Table 90. Global Neurovascular Devices Typical Customers
Table 1. World Neurovascular Devices Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Neurovascular Devices Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Neurovascular Devices Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Neurovascular Devices Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Neurovascular Devices Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Neurovascular Devices Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Neurovascular Devices Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Neurovascular Devices Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Neurovascular Devices Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Neurovascular Devices Players in 2025
Table 12. World Neurovascular Devices Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Neurovascular Devices Company Evaluation Quadrant
Table 14. Head Office of Key Neurovascular Devices Players
Table 15. Neurovascular Devices Market: Company Product Type Footprint
Table 16. Neurovascular Devices Market: Company Product Application Footprint
Table 17. Neurovascular Devices Mergers & Acquisitions Activity
Table 18. United States VS China Neurovascular Devices Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Neurovascular Devices Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Neurovascular Devices Companies, Headquarters (States, Country)
Table 21. United States Based Companies Neurovascular Devices Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Neurovascular Devices Revenue Market Share (2021-2026)
Table 23. China Based Neurovascular Devices Companies, Headquarters (Province, Country)
Table 24. China Based Companies Neurovascular Devices Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Neurovascular Devices Revenue Market Share (2021-2026)
Table 26. Rest of World Based Neurovascular Devices Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Neurovascular Devices Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Neurovascular Devices Revenue Market Share (2021-2026)
Table 29. World Neurovascular Devices Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Neurovascular Devices Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Neurovascular Devices Market Size by Type (2027-2032) & (USD Million)
Table 32. World Neurovascular Devices Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Neurovascular Devices Market Size by Application (2021-2026) & (USD Million)
Table 34. World Neurovascular Devices Market Size by Application (2027-2032) & (USD Million)
Table 35. Stryker Corporation Basic Information, Manufacturing Base and Competitors
Table 36. Stryker Corporation Major Business
Table 37. Stryker Corporation Neurovascular Devices Product and Services
Table 38. Stryker Corporation Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Stryker Corporation Recent Developments/Updates
Table 40. Stryker Corporation Competitive Strengths & Weaknesses
Table 41. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 42. Johnson & Johnson Major Business
Table 43. Johnson & Johnson Neurovascular Devices Product and Services
Table 44. Johnson & Johnson Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Johnson & Johnson Recent Developments/Updates
Table 46. Johnson & Johnson Competitive Strengths & Weaknesses
Table 47. Medtronic Basic Information, Manufacturing Base and Competitors
Table 48. Medtronic Major Business
Table 49. Medtronic Neurovascular Devices Product and Services
Table 50. Medtronic Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Medtronic Recent Developments/Updates
Table 52. Medtronic Competitive Strengths & Weaknesses
Table 53. Terumo Neuro Basic Information, Manufacturing Base and Competitors
Table 54. Terumo Neuro Major Business
Table 55. Terumo Neuro Neurovascular Devices Product and Services
Table 56. Terumo Neuro Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Terumo Neuro Recent Developments/Updates
Table 58. Terumo Neuro Competitive Strengths & Weaknesses
Table 59. Penumbra, Inc. (Neuro) Basic Information, Manufacturing Base and Competitors
Table 60. Penumbra, Inc. (Neuro) Major Business
Table 61. Penumbra, Inc. (Neuro) Neurovascular Devices Product and Services
Table 62. Penumbra, Inc. (Neuro) Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Penumbra, Inc. (Neuro) Recent Developments/Updates
Table 64. Penumbra, Inc. (Neuro) Competitive Strengths & Weaknesses
Table 65. Shanghai MicroPort Medical (Group) Co.?Ltd. Basic Information, Manufacturing Base and Competitors
Table 66. Shanghai MicroPort Medical (Group) Co.?Ltd. Major Business
Table 67. Shanghai MicroPort Medical (Group) Co.?Ltd. Neurovascular Devices Product and Services
Table 68. Shanghai MicroPort Medical (Group) Co.?Ltd. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Shanghai MicroPort Medical (Group) Co.?Ltd. Recent Developments/Updates
Table 70. Shanghai MicroPort Medical (Group) Co.?Ltd. Competitive Strengths & Weaknesses
Table 71. Abbott Vascular Basic Information, Manufacturing Base and Competitors
Table 72. Abbott Vascular Major Business
Table 73. Abbott Vascular Neurovascular Devices Product and Services
Table 74. Abbott Vascular Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Abbott Vascular Recent Developments/Updates
Table 76. Abbott Vascular Competitive Strengths & Weaknesses
Table 77. Medical Murray Basic Information, Manufacturing Base and Competitors
Table 78. Medical Murray Major Business
Table 79. Medical Murray Neurovascular Devices Product and Services
Table 80. Medical Murray Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Medical Murray Recent Developments/Updates
Table 82. Medical Murray Competitive Strengths & Weaknesses
Table 83. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 84. Boston Scientific Major Business
Table 85. Boston Scientific Neurovascular Devices Product and Services
Table 86. Boston Scientific Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Boston Scientific Recent Developments/Updates
Table 88. Boston Scientific Competitive Strengths & Weaknesses
Table 89. Global Key Players of Neurovascular Devices Upstream (Raw Materials)
Table 90. Global Neurovascular Devices Typical Customers
LIST OF FIGURES
Figure 1. Neurovascular Devices Picture
Figure 2. World Neurovascular Devices Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Neurovascular Devices Total Revenue (2021-2032) & (USD Million)
Figure 4. World Neurovascular Devices Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Neurovascular Devices Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Neurovascular Devices Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Neurovascular Devices Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Neurovascular Devices Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Neurovascular Devices Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Neurovascular Devices Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Neurovascular Devices Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Neurovascular Devices Revenue (2021-2032) & (USD Million)
Figure 13. Neurovascular Devices Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Neurovascular Devices Consumption Value (2021-2032) & (USD Million)
Figure 16. World Neurovascular Devices Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Neurovascular Devices Consumption Value (2021-2032) & (USD Million)
Figure 18. China Neurovascular Devices Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Neurovascular Devices Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Neurovascular Devices Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Neurovascular Devices Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Neurovascular Devices Consumption Value (2021-2032) & (USD Million)
Figure 23. India Neurovascular Devices Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Neurovascular Devices by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Neurovascular Devices Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Neurovascular Devices Markets in 2025
Figure 27. United States VS China: Neurovascular Devices Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Neurovascular Devices Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Neurovascular Devices Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Neurovascular Devices Market Size Market Share by Type in 2025
Figure 31. Thrombectomy Devices
Figure 32. Intracranial Stents
Figure 33. Embolization Devices
Figure 34. Flow Diversion Devices
Figure 35. Others
Figure 36. World Neurovascular Devices Market Size Market Share by Type (2021-2032)
Figure 37. World Neurovascular Devices Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 38. World Neurovascular Devices Market Size Market Share by Application in 2025
Figure 39. Stroke Treatment
Figure 40. Aneurysm Treatment
Figure 41. Cerebral Vascular Stenosis Treatment
Figure 42. Traumatic Brain Injury and Intracranial Hemorrhage Treatment
Figure 43. Others
Figure 44. World Neurovascular Devices Market Size Market Share by Application (2021-2032)
Figure 45. Neurovascular Devices Industrial Chain
Figure 46. Methodology
Figure 47. Research Process and Data Source
Figure 1. Neurovascular Devices Picture
Figure 2. World Neurovascular Devices Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Neurovascular Devices Total Revenue (2021-2032) & (USD Million)
Figure 4. World Neurovascular Devices Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Neurovascular Devices Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Neurovascular Devices Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Neurovascular Devices Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Neurovascular Devices Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Neurovascular Devices Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Neurovascular Devices Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Neurovascular Devices Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Neurovascular Devices Revenue (2021-2032) & (USD Million)
Figure 13. Neurovascular Devices Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Neurovascular Devices Consumption Value (2021-2032) & (USD Million)
Figure 16. World Neurovascular Devices Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Neurovascular Devices Consumption Value (2021-2032) & (USD Million)
Figure 18. China Neurovascular Devices Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Neurovascular Devices Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Neurovascular Devices Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Neurovascular Devices Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Neurovascular Devices Consumption Value (2021-2032) & (USD Million)
Figure 23. India Neurovascular Devices Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Neurovascular Devices by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Neurovascular Devices Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Neurovascular Devices Markets in 2025
Figure 27. United States VS China: Neurovascular Devices Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Neurovascular Devices Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Neurovascular Devices Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Neurovascular Devices Market Size Market Share by Type in 2025
Figure 31. Thrombectomy Devices
Figure 32. Intracranial Stents
Figure 33. Embolization Devices
Figure 34. Flow Diversion Devices
Figure 35. Others
Figure 36. World Neurovascular Devices Market Size Market Share by Type (2021-2032)
Figure 37. World Neurovascular Devices Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 38. World Neurovascular Devices Market Size Market Share by Application in 2025
Figure 39. Stroke Treatment
Figure 40. Aneurysm Treatment
Figure 41. Cerebral Vascular Stenosis Treatment
Figure 42. Traumatic Brain Injury and Intracranial Hemorrhage Treatment
Figure 43. Others
Figure 44. World Neurovascular Devices Market Size Market Share by Application (2021-2032)
Figure 45. Neurovascular Devices Industrial Chain
Figure 46. Methodology
Figure 47. Research Process and Data Source
